Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Alamar Biosciences in the transaction. Alamar Biosciences announced it raised $128 million in Series C financing round. The financing...
Alamar Biosciences’ $128 Million Series C Financing Round
Alamar Biosciences’ $80 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Alamar Biosciences on the deal. Alamar Biosciences, a precision proteomics company, announced its $80 million Series B financing led...